Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications-Reference-Cited by-同舟云学术

Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications

Published:2023-10 Issue:10 Volume:23 Page:1590-1602
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Hannan Stefanie J.^ORCID,Iasella Carlo J.^ORCID,Sutton Rachel M.^ORCID,Popescu Iulia D.^ORCID,Koshy Ritchie,Burke Robin,Chen Xiaoping^ORCID,Zhang Yingze^ORCID,Pilewski Joseph M.^ORCID,Hage Chadi A.^ORCID,Sanchez Pablo G.^ORCID,Im Annie^ORCID,Farah Rafic,Alder Jonathan K.^ORCID,McDyer John F.^ORCID

Funder

University of Pittsburgh

National Heart, Lung, and Blood Institute

Medical Center, University of Pittsburgh

Publisher

Elsevier BV

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference44 articles.

1. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: multiorgan Transplantation;Chambers;J Heart Lung Transplant,2018

2. Telomere-mediated lung disease;Alder;Physiol Rev,2022

3. Short telomeres are a risk factor for idiopathic pulmonary fibrosis;Alder;Proc Natl Acad Sci U S A,2008